India has given approval to drug firms including Aurobindo and Karnataka Antibiotics & Pharmaceuticals under a scheme for the promotion of domestic manufacturing of critical bulk drugs, reported Business Standard.
The Production Linked Incentive (PLI) scheme looks to bolster the production of key starting materials (KSMs)/drug intermediates and active pharmaceutical ingredients in the country.
Aurobindo has been green-lighted to set up plants for the production of penicillin and 7-ACA as well as erythromycin thiocyanate, while Karnataka Antibiotics & Pharmaceuticals has been accorded approval for the production of 7-ACA.
Kinvan has also been given the approval for setting up the production facility for clavulanic acid, the news source said.
To read more NewsPoints articles, click here.